Dato-DXd (datopotamab deruxtecan) combined with Imfinzi (durvalumab) with or without carboplatin led to improvements in outcomes with no new safety signals ...

Rising prostate-specific antigen (PSA) levels indicate biochemical recurrence of prostate cancer. Certain prostate cancer treatments used to reduce the risk ...

An alternative to opioid use may reduce the risk of misuse and addition. Alternatives to using opioid pills for patients receiving pancreatic cancer surgery ...

Your browser does not support the audio element.Listen to, "Optimism Abounds in Ovarian Cancer Research." In spring 2021, Kathy Ventre, 56, of Cincinnati, ...

My family and I had been peppering him with questions after scans showed yet another recurrence; frantically in search of some understanding on how my ...

The Food and Drug Administration's (FDA) recent approval of Lonsurf (trifluridine and tipiracil) plus Avastin (bevacizumab) for patients with metastatic ...

A phase 2 trial will investigate a new drug for patients with ROS1-positive cancer. The phase 2 portion of the ARROS-1 clinical trial recently launched, ...

Acceleration needs good evaluation At Cancer Research Horizons, our aim is to accelerate the discovery and development of new therapeutics, ensuring we ...

Adding Adcetris (brentuximab vedotin) to frontline chemotherapy for patients with Hodgkin lymphoma led to improved outcomes, regardless of post-therapy PET ...

Katie Coleman has utilized online support groups and developed a following via TikTok, X (formerly Twitter), Instagram, YouTube and her “Oncology ...